Department of Pediatric Nephrology, Göztepe Teaching and Research Hospital, Istanbul, Turkey.
Perit Dial Int. 2013 May-Jun;33(3):290-6. doi: 10.3747/pdi.2011.00211. Epub 2012 Nov 1.
We aimed to evaluate the efficacy of acute peritoneal dialysis (PD) and clinical outcomes in neonates with acute kidney injury (AKI) and hypernatremic dehydration. ♢
The medical records of 15 neonates with AKI and hypernatremic dehydration who were treated with acute PD were reviewed. The diagnoses were AKI with hypernatremic dehydration with or without sepsis in 13 patients and AKI with hypernatremia and congenital nephropathy in 2 patients. The main indications for PD were AKI with some combination of oligoanuria, azotemia, hyperuricemia, and metabolic acidosis unresponsive to initial intensive medical treatment. ♢
The mean age of the patients at dialysis initiation was 11.9 ± 9 days, and the mean duration of PD was 6.36 ± 4.8 days. In 7 patients (46.7%), hypotension required the use of vasopressors, and in 6 patients (40%), mechanical ventilation was required. Peritoneal dialysis-related complications occurred in 7 patients (46.7%), the most common being catheter malfunction (n = 6). Four episodes of peritonitis occurred in the 15 patients (26.7%), 2 episodes in patients with congenital renal disease and 2 episodes in patients with sepsis and multiorgan failure, who did not survive. Congenital renal disease, septicemia, and the need for mechanical ventilation were important factors influencing patient survival. All patients with no pre-existing renal disease or sepsis recovered their renal function and survived. ♢
In neonates with AKI and hypernatremic dehydration, PD is safe and successful, and in patients without congenital renal disease or sepsis, the prognosis is good. Peritoneal dialysis should be the treatment of choice in neonates with AKI and hypernatremic dehydration who do not respond to appropriate medical treatment.
评估急性腹膜透析(PD)在伴有高钠血症脱水的急性肾损伤(AKI)新生儿中的疗效和临床结局。
回顾性分析 15 例接受急性 PD 治疗的 AKI 伴高钠血症脱水新生儿的病历资料。13 例诊断为伴有或不伴有脓毒症的 AKI 伴高钠血症脱水,2 例诊断为 AKI 伴高钠血症和先天性肾病。PD 的主要适应证为 AKI 伴有少尿、氮质血症、高尿酸血症和代谢性酸中毒,初始强化治疗无效。
患者开始透析时的平均年龄为 11.9±9 天,PD 的平均持续时间为 6.36±4.8 天。7 例(46.7%)患者出现低血压,需要使用血管升压药,6 例(40%)患者需要机械通气。7 例(46.7%)患者发生与 PD 相关的并发症,最常见的是导管功能障碍(n=6)。15 例患者中发生 4 例(26.7%)腹膜炎,2 例为先天性肾病患者,2 例为脓毒症和多器官功能衰竭患者,均未存活。先天性肾病、败血症和需要机械通气是影响患者生存的重要因素。所有无原有肾脏疾病或败血症的患者肾功能均恢复,存活。
在伴有高钠血症脱水的 AKI 新生儿中,PD 是安全且有效的,在无先天性肾病或败血症的患者中,预后良好。对于对适当的药物治疗无反应的 AKI 伴高钠血症脱水的新生儿,PD 应是首选治疗方法。